News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
488,427 Results
Type
Article (28559)
Company Profile (71)
Press Release (459797)
Multimedia
Podcasts (93)
Webinars (8)
Section
Business (147211)
Career Advice (1510)
Deals (24175)
Drug Delivery (60)
Drug Development (58185)
Employer Resources (104)
FDA (10960)
Job Trends (10432)
News (243407)
Policy (21424)
Tag
Academia (1803)
Academic (1)
Accelerated approval (8)
Adcomms (15)
Allergies (72)
Alliances (37481)
ALS (92)
Alzheimer's disease (1109)
Antibody-drug conjugate (ADC) (106)
Approvals (10996)
Artificial intelligence (226)
Autoimmune disease (21)
Automation (16)
Bankruptcy (207)
Best Places to Work (8680)
BIOSECURE Act (9)
Biosimilars (80)
Biotechnology (51)
Bladder cancer (74)
Brain cancer (22)
Breast cancer (297)
Cancer (2273)
Cardiovascular disease (182)
Career advice (1287)
Career pathing (25)
CAR-T (121)
CDC (19)
Cell therapy (396)
Cervical cancer (17)
Clinical research (48264)
Collaboration (834)
Compensation (686)
Complete response letters (12)
COVID-19 (1787)
CRISPR (48)
C-suite (227)
Cystic fibrosis (86)
Data (2512)
Decentralized trials (2)
Denatured (28)
Depression (43)
Diabetes (291)
Diagnostics (4510)
Digital health (15)
Diversity (4)
Diversity, equity & inclusion (30)
Drug discovery (100)
Drug pricing (72)
Drug shortages (20)
Duchenne muscular dystrophy (108)
Earnings (69740)
Editorial (37)
Employer branding (13)
Employer resources (92)
Events (86825)
Executive appointments (589)
FDA (12225)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (2)
Frontotemporal dementia (7)
Funding (676)
Gene editing (105)
Generative AI (22)
Gene therapy (318)
GLP-1 (608)
Government (2956)
Grass and pollen (4)
Guidances (160)
Healthcare (13657)
HIV (37)
Huntington's disease (19)
IgA nephropathy (31)
Immunology and inflammation (115)
Immuno-oncology (6)
Indications (31)
Infectious disease (1895)
Inflammatory bowel disease (123)
Inflation Reduction Act (9)
Influenza (38)
Intellectual property (89)
Interviews (276)
IPO (12765)
IRA (31)
Job creations (2150)
Job search strategy (1068)
Kidney cancer (8)
Labor market (29)
Layoffs (288)
Leadership (20)
Legal (5140)
Liver cancer (56)
Longevity (8)
Lung cancer (328)
Lymphoma (170)
Machine learning (4)
Management (37)
Manufacturing (300)
MASH (75)
Medical device (8957)
Medtech (8962)
Mergers & acquisitions (12018)
Metabolic disorders (659)
Multiple sclerosis (75)
NASH (16)
Neurodegenerative disease (84)
Neuropsychiatric disorders (21)
Neuroscience (1616)
NextGen: Class of 2025 (4422)
Non-profit (3463)
Now hiring (14)
Obesity (301)
Opinion (181)
Ovarian cancer (69)
Pain (77)
Pancreatic cancer (92)
Parkinson's disease (136)
Partnered (12)
Patents (213)
Patient recruitment (106)
Peanut (33)
People (35614)
Pharmaceutical (16)
Pharmacy benefit managers (10)
Phase I (14039)
Phase II (20980)
Phase III (17003)
Pipeline (1429)
Policy (133)
Postmarket research (2110)
Preclinical (6272)
Press Release (41)
Prostate cancer (124)
Psychedelics (28)
Radiopharmaceuticals (190)
Rare diseases (360)
Real estate (3483)
Recruiting (40)
Regulatory (15114)
Reports (26)
Research institute (1647)
Resumes & cover letters (230)
Rett syndrome (7)
RNA editing (6)
RSV (35)
Schizophrenia (68)
Series A (111)
Series B (63)
Service/supplier (7)
Sickle cell disease (50)
Special edition (12)
Spinal muscular atrophy (92)
Sponsored (22)
Startups (2094)
State (1)
Stomach cancer (10)
Supply chain (41)
Tariffs (36)
The Weekly (64)
Vaccines (532)
Venture capital (37)
Weight loss (177)
Women's health (29)
Worklife (13)
Date
Today (55)
Last 7 days (279)
Last 30 days (1381)
Last 365 days (24450)
2025 (13505)
2024 (26673)
2023 (29837)
2022 (37423)
2021 (40213)
2020 (38658)
2019 (33196)
2018 (24537)
2017 (22856)
2016 (22272)
2015 (26266)
2014 (21481)
2013 (18248)
2012 (18656)
2011 (18532)
2010 (17472)
Location
Africa (605)
Alabama (49)
Alaska (4)
Arizona (134)
Arkansas (8)
Asia (26683)
Australia (4574)
California (5810)
Canada (1756)
China (496)
Colorado (259)
Connecticut (273)
Delaware (148)
Europe (65131)
Florida (914)
Georgia (188)
Idaho (28)
Illinois (471)
India (23)
Indiana (290)
Iowa (7)
Japan (180)
Kansas (78)
Kentucky (23)
Louisiana (7)
Maine (41)
Maryland (771)
Massachusetts (4438)
Michigan (169)
Minnesota (294)
Missouri (72)
Montana (12)
Nebraska (13)
Nevada (58)
New Hampshire (34)
New Jersey (1719)
New Mexico (13)
New York (1600)
North Carolina (1137)
North Dakota (7)
Northern California (2634)
Ohio (185)
Oklahoma (12)
Oregon (22)
Pennsylvania (1236)
Puerto Rico (5)
Rhode Island (24)
South America (866)
South Carolina (32)
Southern California (2201)
Tennessee (92)
Texas (832)
United States (21712)
Utah (173)
Virginia (122)
Washington D.C. (58)
Washington State (522)
West Virginia (3)
Wisconsin (54)
488,427 Results for "wolf greenfield and sacks p c".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Innate Pharma Announces Its Participation in H.C. Wainwright and Wolfe Research Healthcare Conferences
June 17, 2025
·
4 min read
Layoffs
Sage Sacks Entire Staff After Supernus Buyout
As of Apr. 22, Sage had 338 full-time employees, all of whom will be laid off effective Aug. 22. The layoffs were announced a few weeks after Maryland’s Supernus Pharmaceuticals acquired Sage for up to $795 million.
June 30, 2025
·
1 min read
·
Tristan Manalac
Press Releases
Element Solutions Inc to Participate in Wolfe Research 2nd Annual Materials of the Future Conference
June 12, 2025
·
1 min read
Press Releases
Theradaptive Appoints Daniel Wolf as Chief Financial Officer, Continuing Executive Transformation
April 22, 2025
·
3 min read
Press Releases
CordenPharma Expands Peptide Platform with more than 500 Million Euro Greenfield Facility Construction in the Basel Region of Switzerland
March 5, 2025
·
6 min read
Press Releases
LivaNova to Present at the Stifel, Wolfe, and Piper Sandler Healthcare Conferences
November 14, 2024
·
2 min read
Press Releases
Anixa Biosciences Chairman and CEO Discusses Pioneering CAR-T Cell Therapy and Breast Cancer Vaccine in Alpha Wolf Trading Interview
February 14, 2025
·
4 min read
Press Releases
10x Genomics to Present at the Wolfe Research 2024 Healthcare Conference
November 8, 2024
·
1 min read
Grey Wolf Therapeutics Closes Oversubscribed $50 Million Series B Financing Expansion, Led by ICG Life Sciences Team, to Accelerate and Expand First-of-its-Kind Antigen Modulation Technology
Grey Wolf Therapeutics today announced the closing of an oversubscribed $50 million Series B financing expansion, bringing the total amount of Series B funds raised to $99 million.
May 23, 2024
·
5 min read
Grey Wolf Therapeutics to Present First Clinical Data for GRWD5769, a First-in-Class ERAP1 Inhibitor, at the 2024 American Society for Clinical Oncology (ASCO) Annual Meeting
Grey Wolf Therapeutics today announced that the first clinical data for the company’s lead immuno-oncology candidate, GRWD5769, will be presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting.
May 29, 2024
·
3 min read
1 of 48,843
Next
